Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Tempium Discontinued Following Abnormal Liver Tests In Phase III

Related Content

Quintiles Increases Contract Win Rate But Suffers From Halt Of Antiplatelets

Sep 20 1999

Roche Ibandronate I.V. Has Four Times Potency Of Fosamax, Firm Says

Jun 28 1999

Actelion To Begin Phase III Bosentan Trial In Second Quarter

Nov 16 1998

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window